The MarketWatch News Department was not involved in the creation of this content.
Dec 02, 2020 (The Expresswire) —
The global hereditary angioedema treatment market size was worth US$ 1883.1 Mn in 2017 and is projected to reach US$ 6533.3 Mn by the end of 2025, exhibiting a CAGR of 16.8% during the forecast period. Hereditary Angioedema Treatment Market Size, Share and Global Trend by Drug Class (C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors), Application (Prophylaxis, Treatment), Route of Administration (IV, Subcutaneous), Distribution Channel (Hospital Pharmacy, Retail Pharmacy) and Geography Forecast till 2025.
Key Players Operating in The Hereditary Angioedema Treatment Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- BIOCRYST PHARMACEUTICALS INC.
- Ionis Pharmaceuticals Inc.
- Attune Pharmaceuticals
- Arrowhead Pharmaceuticals Inc.